Stress cardiomyopathy epidemiology and demographics

Jump to navigation Jump to search

Stress cardiomyopathy Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Stress Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Unstable angina/non ST elevation myocardial infarction in Stress (Takotsubo) Cardiomyopathy

Future or Investigational Therapies

Case Studies

Case #1

Stress cardiomyopathy epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Stress cardiomyopathy epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Stress cardiomyopathy epidemiology and demographics

CDC on Stress cardiomyopathy epidemiology and demographics

Stress cardiomyopathy epidemiology and demographics in the news

Blogs on Stress cardiomyopathy epidemiology and demographics

Directions to Hospitals Treating Stress cardiomyopathy

Risk calculators and risk factors for Stress cardiomyopathy epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]

Overview

The true incidence and prevalence of stress cardiomyopathy is unknown. However, this disease most commonly affects post-menopausal women, with the mean age of diagnosis ranging between 58-75 years.

Epidemiology

Incidence

  • The true incidence of stress cardiomyopathy is unknown and is thought to be underestimated, because there is a number of sub-clinical and milder forms of the disease, which do not come to clinical attention.[1] However, approximately 1-2% of patients thought to have acute coronary syndrome or myocardial infarction at initial presentation eventually receive the diagnosis of stress cardiomyopathy instead.[2][3][4][5]
  • In the United States, the overall incidence of stress cardiomyopathy is estimated at 5.2 per 100,000 cases in women and 0.6 per 100,000 cases in men.[6]

Prevalence

  • The prevalence of stress cardiomyopathy is unknown.

Demographics

Age

  • Stress cardiomyopathy occurs mostly in older people, mostly in post-menopausal women.[2][7][8]
  • The mean age of diagnosis ranges between 58 to 75 years old, with less than 3% of patients being younger than 50 years old at presentation.[2]

Gender

Stress cardiomyopathy is much more common in women, with female patients accounting for 80-100% of patients.[7][9][1][2][8]

References

  1. 1.0 1.1 Omerovic E (2011). "How to think about stress-induced cardiomyopathy?--Think "out of the box"!". Scand. Cardiovasc. J. 45 (2): 67–71. doi:10.3109/14017431.2011.565794. PMID 21401402.
  2. 2.0 2.1 2.2 2.3 Prasad A, Lerman A, Rihal CS (2008). "Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction". Am. Heart J. 155 (3): 408–17. doi:10.1016/j.ahj.2007.11.008. PMID 18294473.
  3. Elian D, Osherov A, Matetzky S, Hod H, Guetta V, Feinberg MS, Di Segni E (2006). "Left ventricular apical ballooning: not an uncommon variant of acute myocardial infarction in women". Clin Cardiol. 29 (1): 9–12. PMID 16477771.
  4. Pillière R, Mansencal N, Digne F, Lacombe P, Joseph T, Dubourg O (2006). "Prevalence of tako-tsubo syndrome in a large urban agglomeration". Am. J. Cardiol. 98 (5): 662–5. doi:10.1016/j.amjcard.2006.03.048. PMID 16923457.
  5. Parodi G, Del Pace S, Carrabba N, Salvadori C, Memisha G, Simonetti I, Antoniucci D, Gensini GF (2007). "Incidence, clinical findings, and outcome of women with left ventricular apical ballooning syndrome". Am. J. Cardiol. 99 (2): 182–5. doi:10.1016/j.amjcard.2006.07.080. PMID 17223415.
  6. Chou AY, Saw J (2014). "Basis for sex-specific expression of Takotsubo cardiomyopathy, cardiac syndrome X, and spontaneous coronary artery dissection". Can J Cardiol. 30 (7): 738–46. doi:10.1016/j.cjca.2013.12.008. PMID 24656530.
  7. 7.0 7.1 Akashi YJ, Goldstein DS, Barbaro G, Ueyama T (2008). "Takotsubo cardiomyopathy: a new form of acute, reversible heart failure". Circulation. 118 (25): 2754–62. doi:10.1161/CIRCULATIONAHA.108.767012. PMC 4893309. PMID 19106400.
  8. 8.0 8.1 Bybee KA, Prasad A, Barsness GW, Lerman A, Jaffe AS, Murphy JG, Wright RS, Rihal CS (2004). "Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome". Am. J. Cardiol. 94 (3): 343–6. doi:10.1016/j.amjcard.2004.04.030. PMID 15276100.
  9. Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL, Sarcon A, Geyer V, Neumann CA, Seifert B, Hellermann J, Schwyzer M, Eisenhardt K, Jenewein J, Franke J, Katus HA, Burgdorf C, Schunkert H, Moeller C, Thiele H, Bauersachs J, Tschöpe C, Schultheiss HP, Laney CA, Rajan L, Michels G, Pfister R, Ukena C, Böhm M, Erbel R, Cuneo A, Kuck KH, Jacobshagen C, Hasenfuss G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Cuculi F, Banning A, Fischer TA, Vasankari T, Airaksinen KE, Fijalkowski M, Rynkiewicz A, Pawlak M, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Franz WM, Empen K, Felix SB, Delmas C, Lairez O, Erne P, Bax JJ, Ford I, Ruschitzka F, Prasad A, Lüscher TF (2015). "Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy". N. Engl. J. Med. 373 (10): 929–38. doi:10.1056/NEJMoa1406761. PMID 26332547.

Template:WH Template:WS